Skip to main content

View full-text article in PMC

. 2023 Jul 10;12:e46863. doi: 10.2196/46863

Table 1.

Study schedule for data measurements.

			Study period and time point (week)
		Enrollment		Allocation	Treatment phase							Follow-up
		–1		0	2	4	6	8	10	12	14		16
Enrollment
	Eligibility screen	✓
	Informed consent	✓
	Physical examination	✓
	Randomization			✓
Interventions
	ACE^a group (n=46)				✓	✓	✓	✓	✓	✓	✓		✓
	Control group (n=46)				✓	✓	✓	✓	✓	✓	✓		✓
Assessments
	BW^b	✓		✓	✓	✓	✓	✓	✓	✓	✓		✓
	BMI	✓		✓	✓	✓	✓	✓	✓	✓	✓		✓
	WC^c	✓		✓	✓	✓	✓	✓	✓	✓	✓		✓
	HC^d			✓	✓	✓	✓	✓	✓	✓	✓		✓
	VAS^e of appetite			✓	✓	✓	✓	✓	✓	✓	✓		✓
Safety
	AE^f				✓	✓	✓	✓	✓	✓

^aACE: acupoint catgut embedding.

^bBW: body weight.

^cWC: waist circumference.

^dHC: hip circumference.

^eVAS: visual analogue scale.

^fAE: adverse event.